Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

PURPOSE: The origin licensing factors minichromosome maintenance 2 (Mcm2) and Geminin have recently been identified as critical regulators of growth and differentiation. Here we have investigated the regulation of these licensing factors together with Ki67 to further elucidate the cell cycle kineti...

書誌詳細
主要な著者:	Dudderidge, T, Stoeber, K, Loddo, M, Atkinson, G, Fanshawe, T, Griffiths, D, Williams, G
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
著者:: Kingsbury, SR, 等
出版事項: (2005)

Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
著者:: Nurhan Güler, 等
出版事項: (2012-01-01)

Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
著者:: Marzena Podhorska-Okolow, 等
出版事項: (2010-11-01)

MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors
著者:: Ritika Raja, 等
出版事項: (2021-01-01)

MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma
著者:: Zohreh Jaafari-Ashkavandi, 等
出版事項: (2019-01-01)

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
著者:: Arisa Nishimukai, 等
出版事項: (2017-01-01)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
著者:: I. Pergolini, 等
出版事項: (2019-10-01)

Gene experison of cell proliferative marker Ki67 in breast cancer
著者:: Golmohammadi R (PhD), 等
出版事項: (2011-09-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
著者:: Christina Marouda, 等
出版事項: (2024-01-01)

Evaluation of Nuclear Morphometry and Ki-67 Proliferative Marker in Astrocytomas: An Ambispective Study
著者:: Palak Nanda, 等
出版事項: (2023-01-01)

A study on the role of proliferative index marker Ki67 in breast carcinoma
著者:: Vijetha Vikram, 等
出版事項: (2022-11-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
著者:: Nasrin Shayanfar, 等
出版事項: (2010-06-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
著者:: Nasrin Shayanfar, 等
出版事項: (2010-05-01)

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
著者:: Huberman Joel, 等
出版事項: (2006-08-01)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
著者:: Muhammad Zain Mehdi, 等

Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67
著者:: Ramesh Babu Telugu, 等
出版事項: (2016-01-01)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
著者:: Gasperetti F, 等
出版事項: (2011-03-01)

Expression of proliferative marker Ki-67 in epithelial dysplasia and squamous cell carcinoma of oral cavity
著者:: Payal Doctor, 等
出版事項: (2023-04-01)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
著者:: Bachmann Ingeborg M, 等
出版事項: (2010-04-01)

Comment on “PCNA and Ki67: Prognostic proliferation markers for oral cancer”
著者:: Muthupandian Saravanan
出版事項: (2024-06-01)

Expression of Ki67 as a Prognostic Marker in Invasive Breast Carcinoma
著者:: Rashi Ahuja, 等
出版事項: (2017-07-01)

Association of degree of expression of ki 67 proliferative cell marker with aggressive giant cell tumor of the bone
著者:: Wan Faisham Nu Man, Wan Ismail
出版事項: (2013)

Geminin is required for the maintenance of pluripotency.
著者:: Golnaz A Tabrizi, 等
出版事項: (2013-01-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
著者:: Dorsay Sadeghian, 等
出版事項: (2022-02-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
著者:: Fahimeh Rezazadeh, 等
出版事項: (2017-09-01)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
著者:: G.S. Starodub, 等
出版事項: (2016-04-01)

The expression of Ki-67 marker in the hydatidiform mole
著者:: Ecaterina Carpenco, 等
出版事項: (2022-12-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
著者:: Fatima S. Al-Sarraf, 等
出版事項: (2015-07-01)

The importance of prognostic markers of tumor progression Ki-67 and р53 in the breast cancer
著者:: Bondareva V.A., 等
出版事項: (2007-01-01)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
著者:: Yunbao Pan, 等
出版事項: (2017-01-01)

Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas Estudo clinicopatológico com avaliação do índice de proliferação celular avaliado pelo Ki-67 em osteossarcomas humanos
著者:: Larissa Cardoso Marinho, 等
出版事項: (2005-12-01)

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
著者:: Dudderidge, T, 等
出版事項: (2007)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
著者:: Agnieszka Pinkowska, 等
出版事項: (2021-12-01)

Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma
著者:: Ela Araz Server, 等
出版事項: (2019-04-01)

Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
著者:: Marković Olivera, 等
出版事項: (2005-01-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
著者:: T. A. Bogush, 等
出版事項: (2023-07-01)

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
著者:: Mojca Založnik, 等
出版事項: (2024-07-01)

Role of Proliferative Marker (Ki-67) and ER, PR in Cervical Epithelial Lesions with Clinicopathological Association: A Cross-sectional Study
著者:: Shrabani Mitra, 等
出版事項: (2025-02-01)

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma
著者:: Sarocha Vivatvakin, 等
出版事項: (2021-07-01)

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma
著者:: Betül Bolat Küçükzeybek, 等
出版事項: (2013-09-01)